On May 15 – May 18, 2022, this poster was on display at ISPOR 2022.
What is the Objective of this Poster?
- The BSA x PGA product shows promise as a single metric to measure DA in
AD patients given the ability to predict STI.
- Given the complexity of collecting clinical trial outcome measures in AD
patients during routine clinical practice, the BSA x PGA product appears to
be a pragmatic solution in generating real-world evidence for AD.
Register to view this poster now!